Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cord blood expanded with um171 (1 trial)
deferoxamine (desferal) (2 trials)
ect-001-cb (1 trial)
ropivacaine (naropin) (2 trials)
sodium chloride (1 trial)
vitamin c (1 trial)
Cerebral Hemorrhage (Phase 2)
Hemorrhage (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neoplasms (Phase 2)
Preleukemia (Phase 2)
Trials (7 total)
Trial APIs (6 total)